GOTHENBURG, SE / ACCESS Newswire / March 28, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, March 28, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that di ...

Anushka Banerjee explores the transformative impact of Public and Patient Involvement and Engagement (PPIE) in medical ...

Discover how AI in life sciences enhances disease diagnosis, enabling faster, more accurate detection and improving patient ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200's ...

(THE CONVERSATION) Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from over-the-counter and prescription medications that treat high ...

Nonmotor symptoms are assuming an increasingly important place in the constellation of clinical traits that characterize Parkinson disease. A multicenter survey of patients with Parkinson disease ...

A bioengineer highlights the potential of low-intensity ultrasound for multiple uses, from enhanced drug delivery to the ...

Rutgers faculty elected to the newest class of fellows of the American Association for the Advancement of Science (AAAS) are ...

The brain's cholesterol regulation and metabolism mechanisms may make some neurons more vulnerable to damage in the early ...

Your feet work hard every day supporting your body, absorbing impact and adapting to different surfaces. But they often get ignored until something ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 were $38.8 million, compared to $40.6 million for the year ended December 31, 2023. The decrease was primarily due ...